Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib Treatment

NCT05517239 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma, Unresectable, Advanced

Interventions

DRUG: Gemcitabine, Oxaliplatin

Sponsor

Yonsei University